Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eletu, Seyi D."'
Autor:
Amin-Chowdhury, Zahin, Bertran, Marta, Abdullahi, Fariyo, Sheppard, Carmen L., Eletu, Seyi D., Litt, David J., Fry, Norman K., Ladhani, Shamez N.
Publikováno v:
In Journal of Infection January 2025 90(1)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Eletu, Seyi D., Sheppard, Carmen L., Thomas, Elizabeth, Smith, Kenneth, Daniel, Priya, Litt, David J., Lim, Wei Shen, Fry, Norman K.
Publikováno v:
Clinical and Vaccine Immunology (formerly CDLI); April 2018, Vol. 24 Issue: 12
Autor:
Vadsala Baskaran, Samuel A. Rose, Hannah Lawrence, Wei Shen Lim, Norman K. Fry, Harry J Pick, Caroline Trotter, Rochelle C. Edwards-Pritchard, Tricia M. McKeever, David Litt, Deborah Ashton, Seyi D Eletu, Carmen L. Sheppard, Priya Daniel, Chamira Rodrigo
Publikováno v:
PLoS Medicine
PLoS Medicine, Vol 17, Iss 10, p e1003326 (2020)
PLoS Medicine, Vol 17, Iss 10, p e1003326 (2020)
Background Vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) is available in the United Kingdom to adults aged 65 years or older and those in defined clinical risk groups. We evaluated the vaccine effectiveness (VE) of PPV23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d382e21902cc10338a0b77590f82312e
Autor:
Amin-Chowdhury Z; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK. Electronic address: zahin.amin@ukhsa.gov.uk., Bertran M; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK., Abdullahi F; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK., Sheppard CL; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK., Eletu SD; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK., Litt DJ; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK., Fry NK; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK; Respiratory and Vaccine Preventable Bacteria Reference Unit, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK., Ladhani SN; Immunisation and Vaccine Preventable Diseases, UK Health Security Agency, Colindale Avenue, London NW9 5EQ, UK; Paediatric Infectious Diseases Research Group, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK.
Publikováno v:
The Journal of infection [J Infect] 2024 Nov 26; Vol. 90 (1), pp. 106363. Date of Electronic Publication: 2024 Nov 26.
Autor:
Eletu SD; Vaccine Preventable Bacteria Section, Public Health England - National Infection Service, Colindale Avenue, London, NW9 5EQ, UK., Sheppard CL; Vaccine Preventable Bacteria Section, Public Health England - National Infection Service, Colindale Avenue, London, NW9 5EQ, UK., Rose S; Vaccine Preventable Bacteria Section, Public Health England - National Infection Service, Colindale Avenue, London, NW9 5EQ, UK., Smith K; Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA., Andrews N; Statistics, Modelling and Economics Department, Public Health England - National Infection Service, Colindale Avenue, London, NW9 5EQ, UK., Lim WS; Department of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK., Litt DJ; Vaccine Preventable Bacteria Section, Public Health England - National Infection Service, Colindale Avenue, London, NW9 5EQ, UK., Fry NK; Vaccine Preventable Bacteria Section, Public Health England - National Infection Service, Colindale Avenue, London, NW9 5EQ, UK.; Immunisation and Countermeasures Division, Public Health England - National Infection Service, Colindale Avenue, London, NW9 5EQ, UK.
Publikováno v:
Access microbiology [Access Microbiol] 2020 Jan 28; Vol. 2 (3), pp. acmi000094. Date of Electronic Publication: 2020 Jan 28 (Print Publication: 2020).